BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2143863)

  • 1. Natural killer cell subsets and alloresponsiveness in renal allograft recipients.
    Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT
    Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863
    [No Abstract]   [Full Text] [Related]  

  • 2. T gamma/delta lymphocytes in renal transplant recipients.
    Raasveld MH; Bloemena E; Surachno S; ten Berge RJ
    Nephrol Dial Transplant; 1992; 7(6):530-3. PubMed ID: 1377808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
    Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
    Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo-in vitro correlates of human rejection using flow cytometry with two-color fluorescence on peripheral blood mononuclear cells.
    Gross U; Thomas F; Matthews C; Thomas J; Cunningham P; Ritter T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1609-10. PubMed ID: 2978885
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistological analysis of T lymphocyte subpopulations in needle core biopsies from OKT3-treated renal allograft recipients.
    Chauhan B; Mohanakumar T; Flye MW
    Transplantation; 1990 Dec; 50(6):1058-60. PubMed ID: 2147792
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenotypic analysis of CD3 + alpha/beta TCR-cells in allograft recipients and in normal lymphoid tissue.
    Schwinzer R; Schlitt HJ; Wonigeit K; Pichlmayr R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):111-2. PubMed ID: 2523117
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB; Ladefoged SD; Larsen S
    APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of the new monoclonal antibody BMA 031 in clinical kidney transplantation.
    Smely S; Weschka M; Hillebrand G; Dendorfer U; Krombach F; Kurrle R; Land W; Hammer C
    Transplant Proc; 1990 Aug; 22(4):1785-6. PubMed ID: 2143862
    [No Abstract]   [Full Text] [Related]  

  • 9. Inverted ratio of CD4/aB heterodimer T cell antigen receptor (TCR aB) to CD8/TCR aB on sorted Leu-7+ (HNK-1) lymphocyte subset in long-term renal allograft recipients.
    Rodriguez SG; Guttmann RD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):257-8. PubMed ID: 2495603
    [No Abstract]   [Full Text] [Related]  

  • 10. The Leu-2+7+ cell subset as a marker of immune activation in renal transplant recipients.
    Brando B; Civati G; Busnach G; Broggi ML; Belli LS; Brunati C; Seveso M; Sommaruga E; Minetti L
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1611-2. PubMed ID: 2484095
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid T cell recovery after prophylactic ALG is associated with pancreas allograft rejection.
    Munn SR; Perkins JD
    Transplant Proc; 1990 Apr; 22(2):619. PubMed ID: 2139264
    [No Abstract]   [Full Text] [Related]  

  • 12. Cloning of human CD3+ T cells and CD3- natural killer cells and requirements for long-term expansion.
    van de Griend RJ; Goedegebuure SP; van Krimpen BA; Bolhuis RL
    Transplant Proc; 1988 Apr; 20(2):149-54. PubMed ID: 2966464
    [No Abstract]   [Full Text] [Related]  

  • 13. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
    Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of CD8+CD11+ cells expressing the T cell receptor in long-term allograft recipients.
    Wonigeit K; Schwinzer R; Nashan B; Vogt P; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):173-8. PubMed ID: 2896404
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of pretransplant immune parameters with the rapidity of onset of acute rejection and renal allograft survival time.
    Shabtai M; Waltzer WC; Pullis CK; Raisbeck A; Shabtai E; Malinowski K; Rapaport FT
    Transplant Proc; 1990 Aug; 22(4):1917-9. PubMed ID: 2389485
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of major histocompatibility complex matching on renal pathology and OKT4/OKT8 (CD4/CD8) ratio in renal allograft rejection.
    Smart YC; Nanra RS; Hibberd AD; Burton RC
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1627-8. PubMed ID: 3152632
    [No Abstract]   [Full Text] [Related]  

  • 18. Expansion of a CD 3+4-8- TCR alpha/beta- T lymphocyte population in renal allograft recipients.
    Volk HD; Reinke P; Neuhaus K; Fiebig H; von Baehr R
    Transplantation; 1989 Mar; 47(3):556-8. PubMed ID: 2646785
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of the IL-2 receptor (p55 and p75) on peripheral blood lymphocytes in renal transplant recipients.
    Fujiwara T; Sakagami K; Niguma T; Haisa M; Kawamura T; Kusaka S; Matsuoka J; Shiozaki S; Fujiwara T; Onoda T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):256-9. PubMed ID: 1824979
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection.
    van den Berg AP; van Son WJ; Tegzess AM; The TH
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1419-20. PubMed ID: 7680157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.